An Aptamer Biosensing Strategy for Label-Free Assay of Dual Acute Myocardial Infarction Biomarkers Built upon AuNPs/Ti3C2-MXenes

16Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

The sensitive quantification of cardiac troponin I (cTnI) and myoglobin (Myo) in blood is essential for an early emergency diagnosis of acute myocardial infarction (AMI). Attributed to AuNPs and a titanium element on the surface of the AuNPs/Ti3C2-MXenes hybrid, each respective aptamer strand can be immobilized on. In this work, a nanohybrid was deposited on amino-functionalized indium tin oxide (ITO) via an Au–N bond; thereafter, it could catch cTnI-specific, thiol-functionalized DNA aptamer through Au–S self-assembly or Myo-aptamer via adsorption and metal chelate interaction between phosphate groups and titanium for specific recognition. Both using [Fe(CN)6]3−/4− as a signaling probe, the differential pulse voltammetric (DPV) current of the cTnI-aptasensor decreased after binding with cTnI, while the other responded to Myo via the impedimetric measurement. These developed biosensors enable the response to the femtogram/mL level cTnI or nanogram/mL level Myo. Remarkably, the proposed aptasensors exhibit high sensitivity and specificity for targets and display great potential for applications in clinic diagnosis.

Cite

CITATION STYLE

APA

Mi, X., Li, H., & Tu, Y. (2023). An Aptamer Biosensing Strategy for Label-Free Assay of Dual Acute Myocardial Infarction Biomarkers Built upon AuNPs/Ti3C2-MXenes. Chemosensors, 11(3). https://doi.org/10.3390/chemosensors11030157

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free